Jean‐pierre Bassand
#152,173
Most Influential Person Now
Jean‐pierre Bassand's AcademicInfluence.com Rankings
Jean‐pierre Bassandmedical Degrees
Medical
#2934
World Rank
#3380
Historical Rank
Cardiology
#292
World Rank
#298
Historical Rank
Download Badge
Medical
Why Is Jean‐pierre Bassand Influential?
(Suggest an Edit or Addition)Jean‐pierre Bassand's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (2012) (4622)
- Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. (2000) (4196)
- Third universal definition of myocardial infarction. (2012) (4123)
- Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). (2008) (2897)
- Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. (2000) (2721)
- Universal definition of myocardial infarction. (2015) (2234)
- [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. (2007) (1974)
- Rivaroxaban in patients with a recent acute coronary syndrome. (2012) (1745)
- Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) (2001) (1291)
- Comparison of fondaparinux and enoxaparin in acute coronary syndromes. (2006) (1125)
- Third universal definition of myocardial infarction. (2012) (921)
- Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. (2006) (855)
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial (2010) (808)
- Early versus delayed invasive intervention in acute coronary syndromes. (2009) (781)
- Third universal definition of myocardial infarction. (2012) (751)
- International Day for the Evaluation of Abdominal Obesity (IDEA): A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary Care Patients in 63 Countries (2007) (749)
- Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. (2010) (549)
- [Guidelines on the diagnosis and management of acute pulmonary embolism]. (2009) (532)
- Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. (2011) (491)
- Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry (2013) (431)
- Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. (2011) (364)
- Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm. (2007) (350)
- Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. (2011) (337)
- False lumen patency as a predictor of late outcome in aortic dissection. (2001) (325)
- Management of unsuccessful thrombolysis in acute massive pulmonary embolism. (2006) (285)
- Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. (2007) (281)
- Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. (2007) (274)
- Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial (2002) (265)
- Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies--with and without intravascular ultrasound guidance. RESIST Study Group. REStenosis after Ivus guided STenting. (1998) (223)
- Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation (2016) (220)
- Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF (2016) (214)
- Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. (1992) (210)
- International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). (2012) (196)
- Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. (2008) (182)
- Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. (2005) (176)
- A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study. (2001) (171)
- Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. (1998) (158)
- Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. (2008) (153)
- Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty. (1997) (142)
- Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. (2002) (140)
- Elderly Patients With Acute Coronary Syndromes Managed Without Revascularization: Insights Into the Safety of Long-Term Dual Antiplatelet Therapy With Reduced-Dose Prasugrel Versus Standard-Dose Clopidogrel (2013) (129)
- Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. (1997) (128)
- One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. (2005) (124)
- Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry (2016) (122)
- Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation (ASPIRE) Pilot Trial (2005) (118)
- Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem. (1997) (118)
- Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in NonST-Segment Elevation Acute Coronary Syndromes (2007) (107)
- In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. (2003) (106)
- Compliance with guidelines and 1-year mortality in patients with acute myocardial infarction: a prospective study. (2005) (105)
- Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. (2013) (104)
- Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. (2010) (104)
- Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function. (1989) (103)
- Subcutaneous Recombinant Hirudin (HBW 023) Versus Intravenous Sodium Heparin in Treatment of Established Acute Deep Vein Thrombosis of the Legs: a Multicentre Prospective Dose-ranging Randomized Trial (1997) (96)
- Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study (2002) (90)
- Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (2015) (87)
- Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. (2010) (86)
- Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR) (2006) (83)
- Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation (2017) (78)
- Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation (2018) (77)
- Efficacy of a Synthetic Pentasaccharide, a Pure Factor Xa Inhibitor, as an Antithrombotic Agent – A Pilot Study in the Setting of Coronary Angioplasty (1999) (76)
- C-reactive protein improves risk prediction in patients with acute coronary syndromes. (2010) (64)
- The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. (2008) (63)
- Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants. (2020) (63)
- Planimetry of aortic valve area using multiplane transoesophageal echocardiography is not a reliable method for assessing severity of aortic stenosis. (1997) (62)
- Cardiac biomarkers and acute coronary syndromes--the Euro Heart Survey of Acute Coronary Syndromes Experience. (2003) (61)
- Anemia for risk assessment of patients with acute coronary syndromes. (2009) (59)
- Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes. (2005) (56)
- Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years old. (1992) (56)
- Immediate versus delayed angioplasty in infarct-related arteries with TIMI III flow and ST segment recovery: a matched comparison in acute myocardial infarction patients (2009) (54)
- Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation: Results From the GARFIELD-AF Registry (2019) (53)
- A Pilot Study of Subcutaneous Recombinant Hirudin (HBW 023) in the Treatment of Deep Vein Thrombosis (1994) (53)
- The Cardiology Information System: the need for data standards for integration of systems for patient care, registries and guidelines for clinical practice. (2002) (52)
- Changes in management of elderly patients with myocardial infarction. (2008) (51)
- Impact of renal dysfunction on 1-year mortality after acute myocardial infarction. (2006) (49)
- Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment. (2008) (48)
- Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction (2006) (44)
- Presence of endothelial colony-forming cells is associated with reduced microvascular obstruction limiting infarct size and left ventricular remodelling in patients with acute myocardial infarction (2011) (43)
- Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group. (2009) (42)
- Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents (2012) (41)
- One-year clinical outcomes of protected and unprotected left main coronary artery stenting (2003) (41)
- Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. (2009) (40)
- Effects of early high-dose streptokinase intravenously on left ventricular function in acute myocardial infarction. (1987) (39)
- Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. (2019) (38)
- Intravascular Ultrasound–Guided Balloon Angioplasty Compared With Stent: Immediate and 6-Month Results of the Multicenter, Randomized Balloon Equivalent to Stent Study (BEST) (2003) (38)
- Medical Practice Guidelines. Separating science from economics. (2003) (37)
- Medical costs of intravascular ultrasound optimization of stent deployment. Results of the multicenter randomized 'REStenosis after Intravascular ultrasound STenting' (RESIST) study (2000) (37)
- [A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study]. (1988) (37)
- Propensity score-matched analysis of effects of clinical characteristics and treatment on gender difference in outcomes after acute myocardial infarction. (2011) (37)
- Lack of Agreement Between Left Ventricular Volumes and Ejection Fraction Determined by Two‐Dimensional Echocardiography and Contrast Cineangiography in Postinfarction Patients (2001) (34)
- Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry (2019) (32)
- Guidelines: making the headlines or confined to the sidelines? (1999) (31)
- Evidence-based vs. 'impressionist' medicine: how best to implement guidelines. (2005) (31)
- GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last. (1994) (29)
- Comparative Effects of APSAC and rt‐PA on Infarct Size and Left Ventricular Function in Acute Myocardial Infarction: A Multicenter Randomized Study (1991) (29)
- One-year clinical outcomes of protected and unprotected left main coronary artery stenting. (2004) (28)
- Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry (2018) (27)
- Bleeding and transfusion in acute coronary syndromes: a shift in the paradigm (2008) (26)
- Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up. (2005) (25)
- The need for resources for clinical research: the European Society of Cardiology calls for European, international collaboration (2002) (25)
- Giant cell myocarditis: an autoimmune disease? (1988) (22)
- Measuring pressure-derived fractional flow reserve through four French diagnostic catheters. (2003) (22)
- Predictors of clinical outcome following percutaneous intervention for in-stent restenosis. (2000) (21)
- Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry. (2019) (21)
- Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosis. (1988) (21)
- SUBCUTANEOUS ADMINISTRATION OF A LOW MOLECULAR WEIGHT HEPARIN (CY 222) COMPARED WITH SUBCUTANEOUS ADMINISTRATION OF STANDARD HEPARIN IN PATIENTS WITH ACUTE DEEP VEIN THROMBOSIS (1987) (20)
- Current antithrombotic agents for acute coronary syndromes: focus on bleeding risk. (2013) (18)
- Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation (2020) (18)
- Prognostic value of albuminuria on 1-month mortality in acute myocardial infarction. (2009) (18)
- Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study. (2000) (18)
- Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry. (2021) (17)
- Improving the quality and dissemination of guidelines: the quest for the Holy Grail. (2000) (17)
- Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group. (1997) (16)
- Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry (2018) (16)
- "Rescue" abciximab for complicated percutaneous transluminal coronary angioplasty. (1998) (16)
- Routine use of fondaparinux in acute coronary syndromes: a 2-year multicenter experience. (2010) (16)
- The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events (2019) (16)
- Effects of increasing balloon pressure on mechanism and results of balloon angioplasty for treatment of restenosis after Palmaz‐Schatz stent implantation: An angiographic and intravascular ultrasound study (1999) (16)
- Predictors of event-free survival after repeat intracoronary procedure for in-stent restenosis; study with angiographic and intravascular ultrasound imaging. (2000) (15)
- Cost effectiveness of thrombolytic treatment for myocardial infarction: comparison of anistreplase, alteplase and streptokinase in 270 patients treated within 4 hours. (1993) (15)
- Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment (2006) (15)
- New European guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction--what are the new and key messages. (2007) (14)
- Managing cardiovascular risk in patients with metabolic syndrome. (2006) (14)
- Balloon angioplasty versus rotational angioplasty in chronic coronary occlusions (the BAROCCO study). (1995) (14)
- Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD‐AF (2021) (14)
- Temporal Fourier analysis applied to equilibrium radionuclide cineangiography importance in the study of global and regional left ventricular wall motion (2004) (14)
- GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke. (2020) (14)
- TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING CORONARY ARTERY BY-PASS SURGERY: RESULTS FROM THE PLATO TRIAL (2010) (13)
- Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism. (1988) (13)
- New AI Prediction Model Using Serial PT-INR Measurements in AF Patients on VKAs: GARFIELD-AF. (2019) (13)
- New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF (2019) (13)
- Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stents (2009) (12)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Left ventricular remodelling after acute myocardial infarction--solved and unsolved issues. (1995) (11)
- Limitation of myocardial infarct size and preservation of left ventricular function by early administration of APSAC in myocardial infarction. (1989) (11)
- Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry. (2018) (11)
- Safety and efficacy of fondaparinux as an adjunctive treatment to thrombolysis in patients with high and intermediate risk pulmonary embolism (2009) (10)
- Impact of renal dysfunction and glucometabolic status on one month mortality after acute myocardial infarction (2007) (10)
- Comparative effectiveness of oral anticoagulants in everyday practice (2021) (10)
- Coronary stent for variant angina: atypical presentation. (1998) (10)
- The need for resources for clinical research: proceedings of a policy conference held at the European Heart House, 27-28 June 2002: executive summary. (2003) (10)
- Factors influencing the quantitication of valvular regurgitation by gated equilibrium radionuclide angiography (2004) (10)
- Unmet needs in antiplatelet therapy (2008) (10)
- Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry (2019) (10)
- Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction. (2006) (9)
- The value of intravascular ultrasound imaging in diagnosis of aortic penetrating atherosclerotic ulcer. (2006) (9)
- The place of fondaparinux in the ESC and ACC/AHA guidelines for anticoagulation in patients with non-ST elevation acute coronary syndromes (2008) (9)
- Changes in unstable coronary atherosclerotic plaque composition after balloon angioplasty as determined by analysis of intravascular ultrasound radiofrequency. (2008) (9)
- Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) (2018) (9)
- Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
- Adaptation of the left ventricular function parameters to dynamic exercise in aortic stenosis. (1988) (8)
- Efficacy and safety of fondaparinux in patients with acute coronary syndromes (2007) (8)
- Treatment of in-stent restenosis with high speed rotational atherectomy and IVUS guidance in small <3.0 mm vessels. (1998) (8)
- Outcomes in newly diagnosed atrial fibrillation and history of acute coronary syndromes: insights from GARFIELD-AF. (2019) (8)
- The number of circulating CD14(+) cells is related to infarct size and postinfarct volumes in ST segment elevation myocardial infarction but not non-ST segment elevation myocardial infarction. (2012) (7)
- Abstract 3294: Fondaparinux versus Control (Placebo or Unfractionated Heparin) as an Adjunct to Thrombolytic Therapy in Acute Myocardial Infarction: an OASIS 6 Substudy (2006) (7)
- Acute coronary syndromes and percutaneous coronary interventions (2009) (7)
- Aortie valve area evolution after percutaneous aortic valvuloplasty (1990) (7)
- Value of intravascular ultrasound imaging in following up patients with replacement of the ascending aorta for acute type A aortic dissection. (2008) (7)
- Clinical implications of inhibition of the late sodium current: ranolazine (2006) (7)
- Simplified percutaneous mitral valvuloplasty with the Inoue balloon. (1998) (6)
- Drug interactions in the setting of acute coronary syndromes and dual anti-platelet therapy (2006) (6)
- Acute Coronary Syndromes and Percutaneous Coronary Interventions: impact of bleeding and blood transfusion. (2009) (6)
- Novel oral anticoagulants in acute coronary syndrome: re-evaluating the thrombin hypothesis. (2014) (6)
- Use of left ventricular function as an end point of thrombolytic therapy. (1991) (6)
- INAPPROPRIATE UTILIZATION OF ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD (GARFIELD) REGISTRY (2012) (6)
- The potential value of intravascular ultrasound imaging in diagnosis of aortic intramural hematoma (2011) (6)
- Potential interest of intra-aorta ultrasound imaging for the diagnosis of aortic penetrating atherosclerotic ulcer (2006) (6)
- Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry (2021) (6)
- Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA2DS2-VASc score ≥ 2? (2019) (6)
- GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation (2021) (5)
- Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction. (1999) (5)
- [Severe thrombopenia from heparin: value of the use of low molecular weight heparin. Apropos of 6 cases]. (1985) (5)
- Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin. (1989) (5)
- Sunday, 26 August 2012 (2012) (5)
- Isotopic findings in anomalous origin of the left coronary artery from the pulmonary artery: report of an adult case. (1991) (5)
- Cerebral emboli of cardiac origin. A report of 71 cases. (1979) (5)
- Diagnosis and Treatment of Non–ST-Segment Elevation Acute Coronary Syndromes (2011) (5)
- Guidelines for anticoagulant use in acute coronary syndromes (2008) (4)
- P3569Impact of body mass index in newly diagnosed atrial fibrillation in the GARFIELD-AF registry (2017) (4)
- Results of a randomized trial comparing apsac and rtpa for the preservation of left ventricular fonction after acute myocardial infarction (1990) (4)
- [Classification of acute coronary syndromes]. (2003) (4)
- Factors influencing the variations of ejection fraction during exercise in chronic aortic regurgitation (2004) (4)
- Intravenous streptokinase versus heparin in recent acute myocardial infarction. Multicentre randomized trial in the Franche Comté area. (1986) (3)
- Networks for improving care in patients with acute coronary syndrome: A framework (2014) (3)
- [Complications of thrombolytic therapy in pulmonary embolism]. (1995) (3)
- Monday, 27 August 2012 (2012) (3)
- A multicenter trial of intravenous APSAC versus rtPA in acute myocadial infarction. Assessment of efficacy and safety (1990) (3)
- [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study]. (1987) (3)
- Cardioprotective effect of intracoronary nifedipine during percutaneous transluminal coronary angioplasty. A French double-blind cross-over multicentre study. (1993) (3)
- 002 Rapid improvement in reperfusion strategy in europe: temporal trends in performance measures for reperfusion therapy in ST elevation myocardial infarction (2011) (3)
- HLA-DR antigen linkage in hypertrophic cardiomyopathy. (1981) (3)
- [Early postoperative (10th day) thrombosis of a Starr mitral prosthesis. Successful fibrinolytic treatment]. (1982) (3)
- [Giant pancreatic pseudocyst with retroperitoneal development and mediastinal and intrapsoic extension]. (1982) (3)
- 025 Benefit of Drug Eluting Stents over Bare Metal Stents after Rotational Atherectomy. A propensity score adjusted comparison in revascularization, mortality and MACE (2010) (2)
- Routine pre-treatment with clopidogrel before diagnostic coronary angiography: the question is right, but what about the answer? (2008) (2)
- Beyond Reperfusion Networks in ST-segment Elevation Myocardial Infarction: Assessment of Quality of Care. (2017) (2)
- Comparison between vertical parallel hole collimator and 30° rotating slant hole collimator for assessing global and regional left ventricular function by radionuclide angiography (2004) (2)
- Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry (2022) (2)
- Abstract 18357: Outcomes and Quality of Anticoagulant Control in Patients Newly Diagnosed with Non-valvular Atrial Fibrillation: Insights from the Worldwide GARFIELD Registry (2012) (2)
- 1354The effect of non-recommended dosing of non-vitamin K antagonist oral anticoagulants (NOACs) on 1-year mortality in patients with newly diagnosed AF? Results from the GARFIELD-AF registry (2018) (2)
- Early local intracoronary platelet activation after drug-eluting stent placement. (2007) (2)
- TREATMENT AND OUTCOMES OF PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ACCORDING TO GUIDELINE-DEFINED ANTICOAGULATION THRESHOLDS: RESULTS FROM THE GARFIELD-AF REGISTRY (2017) (2)
- One-year outcomes in atrial fibrillation patients with versus without a previous stroke or transient ischaemic attack: findings from the international prospective GARFIELD registry (2013) (2)
- [Anticoagulant therapy with recombinant hirudin in patients with thrombopenia induced by heparin]. (1996) (2)
- Application of the Fourier Descriptors Method for Plane Closed Curves to the Analysis of Sequences of Left Ventricular Contours in Cardiac Radionuclide Angiographies (1986) (2)
- 27 A multicenter double-blind trial of intravenous APSAC versus heparin in acute myocardial infarction. The APSIM study (1988) (2)
- How can the European Society of Cardiology ensure compliance with ethical standards? (2016) (2)
- VALUE OF KILLIP CLASSIFICATION FIRST DESCRIBED IN 1,967 FOR RISK STRATIFICATION OF STEMI AND NSTE-ACS IN THE NEW MILLENNIUM: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY (2011) (2)
- Clinical outcome of patients with left anterior descending artery ostial lesions treated with percutaneous coronary intervention: case-matched comparison with bypass surgery. (2003) (2)
- [Reperfusion treatment of acute myocardial infarct. Guidelines of European Cardiological Society]. (2006) (2)
- [Long-term outcome of acute massive pulmonary thromboembolism following thrombolysis]. (2002) (2)
- Assessment of Balloon Angioplasty in Intrastent Restenosis With Intra Coronary Ultrasound (1998) (2)
- Barking up the right tree at last: another step closer to a universal definition of bleeding. (2014) (2)
- A reduction in bleeding in acute coronary syndromes? Let's not rain on the parade! (2010) (2)
- [When to suspect pulmonary embolism in a patient with deep venous thrombosis?]. (2002) (1)
- Low-molecular-weight heparin for deep venous thrombosis. (1988) (1)
- P490 Are ?region based? and ?population based? registries comparable? Comparison of reperfusion therapy and 30 day mortality between a region-based and two population-based registries (2003) (1)
- Chapter 16 Acute Coronary Syndromes (2009) (1)
- [Anisoylated plasminogen streptokinase complex during the acute phase of myocardial infarction. Results of a multicenter double-blind study versus heparin]. (1990) (1)
- [Major thrombopenia induced by heparin treatment. Apropos of 8 cases]. (1983) (1)
- COMPARISON BETWEEN INITIAL AND ACHIEVED ANTICOAGULATION LEVEL WITH PHLEBOGRAPHIC EVOLUTION IN PATIENTS WITH DEEP VEIN THROMBOSIS TREATED BY DIFFERENT HEPARINS (1987) (1)
- Non-ST-segment Elevation Acute Coronary Syndromes 2007 (2012) (1)
- Enoxaparin with or without GPIIb/IIIa inhibition as reperfusion strategy in ST-segment elevation MI - results of the ENTIRE-TIMI 23 trial (2001) (1)
- Polymorphisms in the angiotensin I-converting enzyme and apolipoprotein E genes and late luminal narrowing after coronary angioplasty in men (1996) (1)
- Abstract 2864: Increase in Use of Guidelines-Recommended Treatments is Associated with a Reduction in Mortality in Elderly Patients Admitted for Acute Myocardial Infarction. Results from the "Registre Franc Comtois des Sydromes Coronariens Aigus": 2001 versus 2005 (2006) (1)
- ADMISSION HYPERGLYCEMIA IMPROVES THE GRACE RISK SCORE FOR PREDICTION OF IN-HOSPITAL MORTALITY: INSIGHTS FROM THE EURO HEART SURVEY ACS III (2014) (1)
- [Complications of percutaneous mitral valvuloplasty; comparison of the double balloon and the Inoue techniques]. (1994) (1)
- [HLA-DRW grouping in obstructive myocardiopathy]. (1984) (1)
- P2889The economic burden attributable to atrial fibrillation in nine European countries: perspectives from the GARFIELD-AF registry (2018) (1)
- AS-098 Primary PCI with DES Implantation in Patients with STEMI/LBBB. Euro Heart Survey ACS III Registry (2006-2008) (2011) (1)
- Tolerability of percutaneous coronary interventions in patients receiving nadroparin calcium for unstable angina or non-Q-wave myocardial infarction: the Angiofrax study (2003) (1)
- The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry (2020) (1)
- [Postoperative course of systolic and diastolic indices of left ventricular function in aortic valve stenosis in adults. Exercise test with radionuclide angiography]. (1990) (1)
- Partnership in cardiovascular medicine. A key to success not only for professional organizations. (2001) (1)
- [Long-term outcome of subvalvular aortic stenoses. A comparative study in adults and children]. (1996) (1)
- Complications of percutaneous valve interventions (2006) (1)
- [Determination of ventricular volumes by a non-geometric method using gamma-cineangiography]. (1985) (1)
- [Subcutaneous recombinant hirudin in the treatment of deep venous thrombosis. A pharmacokinetic study]. (1995) (1)
- Major Bleeding Complications in Patients With Stemi Account for a Doubling in Hospital Mortality in Clinical Practice: Lessons From the Euro Heart Survey Acs Registry (2010) (1)
- [Evaluation of management of infarction in the Franche Comté province by the use of the Franche Comté Cardiology Registry, May 2005-May 2006]. (2007) (1)
- Are Elderly Patients with Acute Coronary Syndromes Undertreated? Data from Euro Heart Survey on ACS III Registry (2013) (1)
- Intravascular ultrasound guided PTCA: a way to escape stent mania? (2000) (1)
- [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients]. (1993) (1)
- Abstract 3296: Effects of Fondaparinux in Patients with ST-Segment Elevation Acute Myocardial Infarction Non-Eligible for Reperfusion Treatment (2006) (1)
- Wednesday, 29 August 2012 (2012) (0)
- Stroke and bleed related deaths in newly diagnosed atrial fibrillation patients: insights from the GARFIELD-AF registry (2022) (0)
- Restenosis after intracoronary ultrasound-guided stent deployment; a randomized multicentric study, results on the 6 month angiographic restenosis rate (1998) (0)
- Major changes in the statutes of the European Society of Cardiology (2004) (0)
- Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF (2022) (0)
- [Coronary recanalization in the acute phase of myocardial infarction]. (1995) (0)
- [Anomalies in left ventricular systolic function disclosed by exercise testing in chronic aortic insufficiency. Study by cavitary scintigraphy]. (1986) (0)
- [Which thrombolysis in myocardial infarction?]. (1989) (0)
- [Importance of the angiotensin test in evaluating left ventricular performance in chronic aortic insufficiency]. (1980) (0)
- P4601Differences in two-year outcomes according to type of atrial fibrillation: results from the GARFIELD-AF registry (2017) (0)
- Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry (2021) (0)
- [Variation of 2-3 DPG concentration in red blood cells during the determination of P50 in myocardial infarct patients]. (1973) (0)
- [Severe thrombopenias during heparin therapy. A phenomenon of intra-vascular platelet aggregation]. (1983) (0)
- Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registry (2021) (0)
- DETERMINANTS OF STROKE AND ITS IMPACT ON OUTCOME OF ACS IN CLINICAL PRACTICE IN EUROPE: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY (2011) (0)
- [Course of ejection fraction, regurgitation fraction and ventricular volumes during exertion in chronic aortic insufficiency. Study using technetium 99m gamma-cineangiography]. (1985) (0)
- [Pulmonary embolism. Etiology, physiopathology, diagnosis, course and prognosis, principles of treatment]. (1990) (0)
- [Electrocardiographic practice exercises and diagnoses]. (1979) (0)
- 1123-179 Comparison between rescue surgical embolectomy and repeat thrombolysis after unsuccessful thrombolysis in acute pulmonary embolism (2004) (0)
- Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. (2007) (0)
- P3609Which definition of hypertension best defines thromboembolic risk in patients with atrial fibrillation? Data from the GARFIELD-AF registry (2017) (0)
- Management of non ST segment elevation acute coronary syndromes: a shift in the paradigm. (2008) (0)
- Historical Perspective and Lessons Learned from the Euro Heart Surveys on Acute Coronary Syndromes (2011) (0)
- [Auscultatory peculiarities of the Lillehei-Kaster prosthesis in the mitral position]. (1977) (0)
- 011 Insights from endogenous thrombin generation in patients undergoing percutaneous coronary intervention. A cohort study (2010) (0)
- Abstract 15233: Presence of Endothelial Colony-Forming Cells is Associated With Reduction of Microvascular Obstruction Limiting Infarct Size and Left Ventricular Remodelling: A Magnetic Resonance Imaging Study in Patients With Acute Myocardial Infarction (2010) (0)
- Is Low-Molecular-Weight Heparin Part of Optimal Therapy in Unstable Coronary Artery Disease? (2001) (0)
- Intracoronary stent implantation under intracoronary ultrasound guidance with aspirin and ticlopidine therapy. (2001) (0)
- GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide (2022) (0)
- Plasma Fibrin Degradation Products Evolution in Patients with Deep‐Vein Thrombosis Treated with a Low Molecular Weight Heparin Fraction (CY222) and Standard Heparin (1989) (0)
- [Disseminated intravascular coagulation in heparin-induced thrombopenia]. (1984) (0)
- Left ventricular ultrastructural lesions are independent predictors for 10-year mortality after aortic valve replacement in chronic aortic regurgitation: a study with percutaneous endomyocardial left ventricular biopsy (2002) (0)
- [Platelet antiaggregation treatment in the aftermath of GUSTO IV, TARGET, TACTICS, and CURE trials]. (2002) (0)
- JAMA Peer Reviewers for 2003 (2017) (0)
- [Proceedings: Erythrocyte 2,3-diphosphoglycerate during the development of myocardial infarct. Concerning 118 cases]. (1975) (0)
- Abstract 13309: Atrial Fibrillation Predicts Hospital Mortality in STEMI but not in NSTE-ACS in Clinical Practice - Results of the Euro Heart Survey ACS-Registry (2013) (0)
- Invasive cardiovascular needs in South Africa: a view from afar up close. (2018) (0)
- [The status of clinical research in France]. (2001) (0)
- Comparative efficiency and safety of early injection of apsac rtpa in acute myocardial infarction a multicenter randomized study (1990) (0)
- 987-106 Accuracy of Aortic Valve Area Measurement by Multiplane Transesophageal Echocardiography in Aortic Stenosis (1995) (0)
- [Severe pulmonary embolism: value of clinical findings and complementary investigations]. (1995) (0)
- Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score? (2019) (0)
- Left ventricular ejection fraction, enzyme release, and stent implantation are independent predictors of late clinical outcome after late opening of infarct-related occlusion (2003) (0)
- Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria (2021) (0)
- Abstract 4401: Anticoagulant Treatment Before Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: A Propensity Score Adjusted Comparison Between No Pre-treatment, Unfractionated Heparin, Enoxaparin and Fondaparinux (2009) (0)
- [Hemodynamic effects of prazosin in chronic congestive heart failure]. (1980) (0)
- [Critical study and value of the determination of 2-3 diphosphoglycerate and of P 50 determination during myocardial infarct]. (1973) (0)
- [Anatomical and coronary angiography data on coronary anastomosis]. (1991) (0)
- [Efficacy and safety of thrombolytic therapy in the elderly with severe pulmonary embolism]. (1995) (0)
- Effect of Pravastatin on Angiographic Restenosis After Coronary Balloon Angioplasty fn1fn1This study was supported by a grant from Bristol Myers Squibb Laboratories, Paris. (1997) (0)
- Influence of CYP2C9 polymorphism on fluindione dose requirement and anticoagulation (2003) (0)
- Late reopening with angioplasty of totally occluded infarct-related arteries prevents left ventricular remodelling after myocardial infarction (1995) (0)
- [Strategies of thrombolysis in the pre-hospital phase in infarction]. (1989) (0)
- OPUS and routine angiography (2000) (0)
- Abstract 1665: Variation of Plaque Composition and Tissue Redistribution After Balloon Angioplasty in Coronary Atherosclerotic Lesions: Study Using "Virtual Histology" by Spectral Analysis of Intravascular Ultrasound Radiofrequency Data (2006) (0)
- Major changes in the statutes of the European Society of Cardiology. (2004) (0)
- [Hemodynamic effects of prazosin in heart failure]. (1979) (0)
- Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF (2020) (0)
- Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry (2020) (0)
- [Treatment of deep venous thrombosis with fractions of low molecular weight heparin]. (1988) (0)
- AS-048 In-Hospital Outcome of Patients with Acute Coronary Syndromes and Anemia at Presentation. Euro Heart Survey ACS III Registry (2006-2008) (2011) (0)
- [Hypercholesterolemia, the future of drug associations]. (2004) (0)
- [Crural paralysis complicating anticoagulant therapy and its surgical treatment]. (1977) (0)
- Percutaneous Coronary Interventions and Stenting/CABG in Non‐ST‐Segment Elevation Acute Coronary Syndromes (2009) (0)
- Chapter 70 Anaemia and transfusion (2010) (0)
- [Thrombolytic treatment of pulmonary embolism. The end of armament race?]. (1995) (0)
- [Study of new thrombolytic agents in myocardial infarction: a multicenter randomized trial (APSAC versus rt-PA)]. (1992) (0)
- Abstract 571: Prognostic Value of Albuminuria on One Month Mortality in Acute Myocardial Infarction (2008) (0)
- Interest of exercise stress testing after implantation of an automatic implantable cardioverter-defibrillator (1998) (0)
- Abstract 387: Chronic Pravastatin Therapy Increases Outgrowth Endothelial Progenitor Cells in Patients with Stable Coronary Artery Disease (2006) (0)
- IMPACT OF IMPAIRED RENAL FUNCTION ON ACUTE TREATMENT AND HOSPITAL MORTALITY OF NSTE-ACS IN CLINICAL PRACTICE IN EUROPE: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY (2010) (0)
- Contents, Vol. 16, Supplement 3, 1986 (1986) (0)
- Belgian Society of Cardiology Belgian Heart Rhythm Association (BeHRA) (2011) (0)
- New evidence for angiotensin-converting enzyme inhibition in stroke, cardiac and renal patients: the cardiological approach (2003) (0)
- RISK-TREATMENT-PARADOX IN STEMI WITH IMPAIRED RENAL FUNCTION IN CLINICAL PRACTICE IN EUROPE: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY (2010) (0)
- [Effect of thrombolytic agents on infarct size and left ventricle systolic function in myocardial infarction]. (1990) (0)
- 323 Interest of dobutamine stress echocardiography for the diagnosis of silent ischemia in diabetic patients (1999) (0)
- [Bronchopulmonary infection in resuscitation in tracheotomized patients]. (1974) (0)
- [Method of isotopic determination of aortic valve regurgitation]. (1984) (0)
- THE PRESCRIBING OF ANTIPLATELET THERAPY ONLY IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: RESULTS FROM THE GARFIELD-AF REGISTRY (2017) (0)
- PRESENCE OF ENDOTHELIAL COLONY-FORMING CELLS AT ADMISSION IS ASSOCIATED WITH A REDUCTION IN INFARCT SIZE AT 6 MONTHS FOLLOW-UP: A MAGNETIC RESONANCE IMAGING STUDY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (2010) (0)
- Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry (2023) (0)
- Is cardiovascular death a primary driver of mortality in higher age groups of patients with non-valvular atrial fibrillation? Results from the GARFIELD-AF Registry (2014) (0)
- Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry (2021) (0)
- Low-Molecular-Weight Heparin and Other Antithrombotic Agents in the Setting of a Fast-Track Revascularization in Unstable Coronary Artery Disease (2000) (0)
- 805-2 Faster but not more Complete Thrombolysis with Tissue Plasminogen Activator than with Streptokinase in Massive Pulmonary Embolism (1995) (0)
- ATRIAL FIBRILLATION TREATMENT PARADOX: CHARACTERISTICS OF AND FIRST-YEAR EVENTS IN PATIENTS NOT TREATED WITH VITAMIN-K ANTAGONISTS COMPARED TO TREATED PATIENTS. THE GARFIELD REGISTRY (2013) (0)
- Comparative results of percutaneous aortic valvuloplasty and aortic valve replacement in elderly patients (1991) (0)
- P3848Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA2DS2VASc score of 2 or higher? (2018) (0)
- One-year outcomes of unprotected and protected left main stenting in the current era (2002) (0)
- 458 The flow convergence region (PISA) method is not a good estimate of mitral valve area before and after percutaneous mitral commissurotomy (1999) (0)
- Welcome Address by Prof. A. Serradimigni (1986) (0)
- Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents the level of stroke risk in (2012) (0)
- [Electrocardiographic exercises and diagnosis]. (1977) (0)
- [Application of temporal Fourier analysis to gamma-cineangiography with technetium 99m. Value in the study of left ventricular total and regional motion]. (1982) (0)
- Is exercised-induced left ventricular dysfunction in aortic regurgitation substantiated by a histological substratum (1990) (0)
- Separating science from economics (2003) (0)
- Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry (2020) (0)
- [Percutaneous mitral commissurotomy: final departure of the balloon?]. (2000) (0)
- Use of glycoprotein IIb/IIIa receptor blockers before and during percutaneous coronary intervention for acute coronary syndromes versus stable angina in consecutive patients in Europe: Results of the international SHAKESPEARE registry (2003) (0)
- 巨细胞病毒感染与冠状动脉支架内新生内膜组织量的关系 (2003) (0)
- IMPACT OF PRIOR CLOPIDOGREL USE ON ISCHEMIC OUTCOMES AMONG MEDICALLY MANAGED PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES: RESULTS FROM THE TRILOGY ACS TRIAL (2014) (0)
- Abstract 12712: Gender Disparities in the Management and In-Hospital Outcomes Acute Myocardial Infarction: Temporal Changes Between 2006 and 2008. Insights from the Euro Heart Survey ACS III registry (2011) (0)
- IMPROVEMENT OF EARLY INVASIVE TREATMENT FOR NSTE-ACS OVER TIME IN CLINICAL PRACTICE IN EUROPE: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY (2011) (0)
- Subject Index, Vol. 16, Supplement 3, 1986 (1986) (0)
- Abstract 12958: Betablocker Use in Patients with Chronic Pulmonary Disease During Acute Phase of Myocardial Infarction. Insights from Euro Heart Survey Acute Coronary Syndromes III (2012) (0)
- 243 Effects of the clinical characteristics and treatments on gender difference in outcomes after acute myocardial infarction (2010) (0)
- PERFORMANCE MEASURES IN ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: 2 YEARS TEMPORAL CHANGES AND ROOM FOR IMPROVEMENT. INSIGHTS FROM THE EURO HEART SURVEY ACS III REGISTRY (2011) (0)
- Abstract 5596: Temporal Changes in Management of Elderly Patients with Myocardial Infarction: Impact on Mortality (2008) (0)
- ENDOTHELIAL COLONY-FORMING CELLS ARE ASSOCIATED WITH INFARCT SIZE REDUCTION THROUGH REDUCTION OF MICROVASCULAR OBSTRUCTION (2010) (0)
- P4800Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score? (2018) (0)
- EARLY MORTALITY IN PATIENTS WITH NEW ONSET ATRIAL FIBRILLATION: RESULTS FROM THE GARFIELD-AF REGISTRY (2017) (0)
- PERFORMANCE MEASURES FOR IN-HOSPITAL MANAGEMENT OF ACUTE CORONARY SYNDROMES IN EUROPE (2010) (0)
- Optimizing Management of Acute Coronary Syndromes Without St Segment Elevation: Update 2004 (2003) (0)
- [Exertion-induced parameters of left ventricular function in patients with chronic cardiac insufficiency. An isotope study]. (1988) (0)
- Abstract 3481: Increase in Predictive Value of the TIMI Risk Index for 30 Day Mortality by Addition of Two "Basic" Biomarkers: Plasma Fasting Glucose and Creatinine Levels. Results from the "Registre Franc Comtois des Syndrome Coronariens Aigus" (2006) (0)
- P4790Haematuria is not elevated in AF patients treated with NOACs versus VKAs: GARFIELD-AF study (2019) (0)
- DETERMINANTS OF MAJOR BLEEDING COMPLICATIONS AND ITS IMPACT ON HOSPITAL OUTCOME IN NSTE-ACS IN CLINICAL PRACTICE: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY (2010) (0)
- Fondaparinux: a new anti- thrombotic treatment strategy in venous thromboembolism and acute coronary syndromes (2008) (0)
- 046 C-Reactive Protein Improves Risk Prediction in Patients with Acute Coronary Syndromes (2010) (0)
- P2895Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry (2018) (0)
- Advantage of color Doppler flow imaging in the assessment of mitral regurgitation and atrial septal defect after percutaneous mitral valvotomy (1992) (0)
- [Serious heparin-induced thrombopenia in the treatment of venous thrombosis of the lower limbs]. (1983) (0)
- [Deep venous thrombosis of the lower limbs. Etiology, physiopathology, diagnosis, course, prognosis, treatment]. (1994) (0)
- Average neointimal tissue proliferation after stenting cannot be predicted from clinical or angiographic variables: an intravascular ultrasound study (2002) (0)
- Anticoagulant Therapy in Acute Coronary Syndromes with Focus on Fondaparinux (2011) (0)
- [Comparative anti-ischemic activity of atenolol and diltiazem. Crossed single-blind randomized study using a computerized exercise test]. (1985) (0)
- William Harvey Trophy: honouring the discoverer of circulation with a round of golf (2008) (0)
- [Mitral valve stenosis. Etiology, physiopathology, diagnosis, clinical course]. (1992) (0)
- [Intravenous streptokinase versus heparin in fresh acute myocardial infarct. Randomized multicenter study in Franche-Comté]. (1986) (0)
- Planimetry ofaortic valve areausing multiplane transoesophageal echocardiography isnota reliable methodforassessing severity ofaortic stenosis (2011) (0)
- Right-to-left atrial shunting associated with aortic root aneurysm: A rare cause of platypnea-orthodeoxia syndrome (2010) (0)
- 827-6 Underuse of glycoprotein IIb/IIIa receptor blockers in diabetics undergoing percutaneous coronary intervention for acute coronary syndromes in current clinical practice in Europe: Results of the International Shakespeare registry (2004) (0)
- Tolerability of percutaneous coronary interventions in patients receiving nadroparin calcium for unstable angina or non-Q-wave myocardial infarction: the Angiofrax study. (2003) (0)
- The relations between the ESC and the European Union. Major initiatives to come in health and cardiovascular research. (2003) (0)
- P1108 Reperfusion therapy in ST-elevation myocardial infarction: results from the Franche-Comte registry of acute coronary syndromes. Reasons for non-reperfusion therapy (2003) (0)
- ACYL PLASMINOGEN STREPTOKINASE VERSUS HEPARIN IN RECENT ACUTE MYOCARDIAL INFARCTION. PRELIMINARY REPORT OF A FRENCH INTERUNIVERSITY TRIAL (1987) (0)
- [Intravenous streptokinase versus heparin in recent acute myocardial infarction. Randomized multicenter study in the Franche-Comté]. (1986) (0)
This paper list is powered by the following services:
